Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC (70 FR 70236). The CY 2007 PFS final rule with comment period (72 FR 66260) then finalized portions of the July 6, 2005 IFC that had not already been finalized. The CAP is an alternative to the ASP (buy and bill) methodology of obtaining certain Part B drugs used incident to physicians’ services. Physicians who choose to participate in the CAP obtain drugs from vendors selected through a competitive bidding process and approved by CMS. Under the CAP, physicians agree to obtain all of the approximately 190 drugs on the CAP drug list from an approved CAP vendor. A vendor retains title to the drug until it is administered, bills Medicare for the drug, and bills the beneficiary for cost sharing amounts once the drug has been administered. The physician bills Medicare only for administering the drug to the beneficiary. The CAP currently operates with a single CAP drug category. CAP claims processing began on July 1, 2006. After the CAP was implemented, section 108 of the MIEA–TRHCA made changes to the CAP payment methodology. Section 108(a)(2) of the MIEA–TRHCA requires the Secretary to establish (by program instruction or otherwise) a post-payment review process (which may include the use of statistical sampling) to assure that payment is made for a drug or biological only if the drug or biological has been 154
CMS-1403-FC administered to a beneficiary. The Secretary is required to recoup, offset, or collect any overpayments. This statutory change took effect on April 1, 2007. Conforming changes were proposed in the CY 2008 PFS proposed rule (72 FR 38153) and finalized in the CY 2008 PFS final rule with comment period (72 FR 66260). In the CY 2009 PFS proposed rule, we proposed several refinements to the CAP regarding the annual CAP payment amount update mechanism, the definition of a CAP physician, the restriction on physician transportation of CAP drugs, and the dispute resolution process (73 FR 38522). However, since the publication of our proposed rule, we have announced the postponement of the CAP for 2009 due to contractual issues with the successful bidders. As a result, CAP physician election for participation in the CAP in 2009 is not being held this Fall, and CAP drugs will not be available from an Approved CAP Vendor for dates of service after December 31, 2008. Moreover, we are currently soliciting public feedback on the CAP from participating physicians, potential vendors, and other interested parties. We are soliciting public comments about a range of issues, including, but not limited to the following issues: the categories of drugs provided under the CAP; the distribution of areas that are 155
- Page 103 and 104: CMS-1403-FC needed regarding a crit
- Page 105 and 106: CMS-1403-FC errors; enhanced patien
- Page 107 and 108: CMS-1403-FC 99233). For CY 2006, we
- Page 109 and 110: CMS-1403-FC follow-up inpatient con
- Page 111 and 112: CMS-1403-FC As noted previously, CP
- Page 113 and 114: CMS-1403-FC face-to-face encounter
- Page 115 and 116: CMS-1403-FC visits requested by the
- Page 117 and 118: CMS-1403-FC Follow-up inpatient tel
- Page 119 and 120: CMS-1403-FC that were appropriate t
- Page 121 and 122: CMS-1403-FC HCPCS codes 96150 throu
- Page 123 and 124: CMS-1403-FC G0332). The Medicare pa
- Page 125 and 126: CMS-1403-FC code G0332. For CY 2009
- Page 127 and 128: CMS-1403-FC Response: The separate
- Page 129 and 130: CMS-1403-FC preadministration-relat
- Page 131 and 132: CMS-1403-FC pricing of IVIG and Med
- Page 133 and 134: CMS-1403-FC CPT Code Short Descript
- Page 135 and 136: CMS-1403-FC percent for the subsequ
- Page 137 and 138: CMS-1403-FC in the same session, on
- Page 139 and 140: CMS-1403-FC jeopardizes beneficiary
- Page 141 and 142: CMS-1403-FC As discussed in the pro
- Page 143 and 144: CMS-1403-FC Note: Under the PFS, CP
- Page 145 and 146: CMS-1403-FC The methodology for dev
- Page 147 and 148: CMS-1403-FC drugs furnished through
- Page 149 and 150: CMS-1403-FC Response: We disagree w
- Page 151 and 152: CMS-1403-FC available to support a
- Page 153: CMS-1403-FC that there are complica
- Page 157 and 158: CMS-1403-FC as we assess potential
- Page 159 and 160: CMS-1403-FC add a modifier to their
- Page 161 and 162: CMS-1403-FC application of the AQ m
- Page 163 and 164: CMS-1403-FC 0.7000. ● A reduction
- Page 165 and 166: CMS-1403-FC so the CY 2009 base com
- Page 167 and 168: CMS-1403-FC patient utilization gro
- Page 169 and 170: CMS-1403-FC make those estimates. A
- Page 171 and 172: CMS-1403-FC After removing the enro
- Page 173 and 174: CMS-1403-FC For CY 2009, we propose
- Page 175 and 176: CMS-1403-FC plain language over pol
- Page 177 and 178: CMS-1403-FC four quarters of ASP pr
- Page 179 and 180: CMS-1403-FC composite rates. The wa
- Page 181 and 182: CMS-1403-FC from the figure in the
- Page 183 and 184: CMS-1403-FC that our goal is the ev
- Page 185 and 186: CMS-1403-FC the average wage index
- Page 187 and 188: CMS-1403-FC Labor Statistics, to de
- Page 189 and 190: CMS-1403-FC been previously deemed
- Page 191 and 192: CMS-1403-FC CBSA where the campuses
- Page 193 and 194: CMS-1403-FC composite rates during
- Page 195 and 196: CMS-1403-FC target amount of compos
- Page 197 and 198: CMS-1403-FC admission. That is, the
- Page 199 and 200: CMS-1403-FC that CMS consider issue
- Page 201 and 202: CMS-1403-FC hold the provider in wh
- Page 203 and 204: CMS-1403-FC Comment: Commenters rai
<strong>CMS</strong>-1403-FC<br />
administered to a beneficiary. The Secretary is required<br />
to recoup, offset, or collect any overpayments. <strong>This</strong><br />
statutory change took effect on April 1, 2007. Conforming<br />
changes were proposed in the CY 2008 PFS proposed rule<br />
(72 FR 38153) and finalized in the CY 2008 PFS final rule<br />
with comment period (72 FR 66260).<br />
In the CY 2009 PFS proposed rule, we proposed several<br />
refinements to the CAP regarding the annual CAP payment<br />
amount update mechanism, the definition of a CAP physician,<br />
the restriction on physician transportation of CAP drugs,<br />
and the dispute resolution process (73 FR 38522). However,<br />
since the publication of our proposed rule, we have<br />
announced the postponement of the CAP for 2009 due to<br />
contractual issues with the successful bidders. As a<br />
result, CAP physician election for participation in the CAP<br />
in 2009 is not being held this Fall, and CAP drugs will not<br />
be available from an Approved CAP Vendor for dates of<br />
service after December 31, 2008.<br />
Moreover, we are currently soliciting public feedback<br />
on the CAP from participating physicians, potential<br />
vendors, and other interested parties. We are soliciting<br />
public comments about a range of issues, including, but not<br />
limited to the following issues: the categories of drugs<br />
provided under the CAP; the distribution of areas that are<br />
155